← Scroll for more →
Exozymes Inc. (EXOZ)
Biological Products, (No Diagnostic Substances)
Latest Price
$4.13
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.43
P/B Ratio
9.58
Institutional Ownership
1.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 55.0K | -- | 0.59% | +32.8K | 2026-06-30 |
| Davidson Kahn Capital Management, LLC | 25.0K | -- | 0.27% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 23.4K | -- | 0.25% | +1.5K | 2026-06-30 |
| BlackRock, Inc. | 9.6K | -- | 0.10% | +2.8K | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 9.4K | -- | 0.10% | -- | 2026-06-30 |
| Morgan Stanley | 1.3K | -- | 0.01% | -- | 2026-06-30 |
| Tower Research Capital LLC (TRC) | 349 | -- | 0.00% | -968 | 2026-06-30 |
| Mercer Global Advisors Inc | 250 | -- | 0.00% | -- | 2026-06-30 |
| UBS Group AG | 203 | -- | 0.00% | -4.4K | 2026-06-30 |